| LDR | | 02739cmm u2200589 i 4500 |
| 001 | | 000000322794 |
| 003 | | OCoLC |
| 005 | | 20230613115301 |
| 006 | | m d |
| 007 | | cr ||||||||||| |
| 008 | | 220311s2022 flu ob 001 0 eng |
| 010 | |
▼a 2021059396 |
| 019 | |
▼a 1342115825 |
| 020 | |
▼a 9781000594676
▼q (epub) |
| 020 | |
▼a 100059467X |
| 020 | |
▼a 9781003048565
▼q (ebook) |
| 020 | |
▼a 1003048560 |
| 020 | |
▼a 9781000594638
▼q (electronic bk.) |
| 020 | |
▼a 1000594637
▼q (electronic bk.) |
| 020 | |
▼z 9780367500269
▼q (paperback) |
| 020 | |
▼z 9780367500290
▼q (hardback) |
| 035 | |
▼a 3282745
▼b (N$T) |
| 035 | |
▼a (OCoLC)1305944541
▼z (OCoLC)1342115825 |
| 040 | |
▼a DLC
▼b eng
▼e rda
▼c DLC
▼d N$T
▼d 248032 |
| 042 | |
▼a pcc |
| 049 | |
▼a MAIN |
| 050 | 00 |
▼a RA410.5 |
| 082 | 00 |
▼a 338.4/33621
▼2 23/eng/20220325 |
| 100 | 1 |
▼a Toumi, Mondher,
▼e author. |
| 245 | 10 |
▼a Managed entry agreements and funding for expensive therapies /
▼c Mondher Toumi, Szymon Jaroslawski.
▼h [electronic resource] |
| 250 | |
▼a First edition. |
| 264 | 1 |
▼a Boca Raton :
▼b CRC Press,
▼c 2022. |
| 300 | |
▼a 1 online resource. |
| 336 | |
▼a text
▼b txt
▼2 rdacontent |
| 337 | |
▼a computer
▼b c
▼2 rdamedia |
| 338 | |
▼a online resource
▼b cr
▼2 rdacarrier |
| 490 | 0 |
▼a Pharmaceuticals, health economics and market access |
| 504 | |
▼a Includes bibliographical references and index. |
| 505 | 0 |
▼a Introduction to managed entry agreements -- From coverage with evidence development to individual performance-based agreements in Italy -- Coverage with evidence development for multiple sclerosis drugs in the UK -- a "costly failure"? -- Novel funding models for expensive therapies -- Definition and classification of MEAs -- Country comparison of the implementation of managed entry agreements. |
| 520 | |
▼a "Managed Entry Agreements and Funding for Expensive Therapies examines the concept of MEA, detailing how depreciation of some specific therapies through intangible amortization is unavoidable"--
▼c Provided by publisher. |
| 588 | |
▼a Description based on print version record and CIP data provided by publisher. |
| 590 | |
▼a OCLC control number change |
| 650 | 0 |
▼a Medical care
▼x Cost control. |
| 650 | 0 |
▼a Drugs
▼x Testing. |
| 650 | 0 |
▼a Drugs
▼x Prices. |
| 650 | 0 |
▼a Drug accessibility. |
| 655 | 4 |
▼a Electronic books. |
| 700 | 1 |
▼a Jaroslawski, Szymon,
▼e author. |
| 776 | 08 |
▼i Print version:
▼a Toumi, Mondher.
▼t Managed entry agreements and funding for expensive therapies
▼b First edition.
▼d Boca Raton : CRC Press, 2022
▼z 9780367500269
▼w (DLC) 2021059395 |
| 856 | 40 |
▼3 EBSCOhost
▼u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3282745 |
| 938 | |
▼a EBSCOhost
▼b EBSC
▼n 3282745 |
| 990 | |
▼a 관리자 |
| 994 | |
▼a 92
▼b N$T |